Funding — Page 17
Rounds, valuations, term sheets.
- Allocortech reports $6.67M sold in offering for drone avionics
Founders Brian Viele and Matthew Walker built the Virginia supplier to spare aircraft developers from integrating every control system themselves. A new Form D reports $6.67M sold under a larger offering, but does not specify the securities or identify the investors.
- Mamatha Chamarthi's Lumiom seeks $3M to put enterprise AI on the P&L
A September 8th SEC filing reports that Lumiom sold a $100,000 SAFE to one investor toward its $3 million offering target.
- Roboligent reports $2.5M offering to one investor as robots move beyond rehab
A September 8th SEC filing reports one investor; the company also completed a $1.8M Air Force rehabilitation project in June.
- Helene Huby raises $450M to give Europe a ride home from orbit
The Exploration Company will fund its reusable Nyx capsule and Storm engine as ESA seeks an ISS cargo-return demonstration ideally in 2028.
- Herdr raises $6M to put a team behind its solo agent runtime
Bessemer led the seed round as founder Can Celik turns Herdr's open-source runtime for persistent coding agents into a developer-tools company.
- Antioch Robotics raises $32M to turn robot testing into a software loop
Greylock led the round less than five months after Antioch's seed, backing repeat founders building cloud simulation for physical AI.
- Celero raises $275M at a $3B-plus valuation for AI networking chips
Broadcom and ClariPhy veterans Nariman Yousefi and Oscar Agazzi paired the round with a claimed 2-nanometer coherent DSP milestone.
- Bluecore Energy raises $50M to move floating reactors toward licensing
Silverton led the seed seven weeks after launch, funding engineering, regulatory work, fuel procurement and Bluecore's Long Beach prototype.
- Forus raises $150M at a $3B valuation, four months after hitting $1B
Sahir Jaggi's medication-access startup is using a free provider-and-patient product to build a distribution network, with Bain Capital Ventures leading the Series C.
- Stoke Space raises $1B before orbit to build a 15-ton Nova
The Series E, co-led by Point72 Ventures and Spark Capital, is intended to fund Pathfinder's 2027 orbital flight and a 15-ton successor targeted for 2029.
- Mistral raises €3B at €21B-plus valuation to build its own compute
Samsung led the round, giving Arthur Mensch an industrial partner and the capital to turn Mistral's sovereignty pitch into infrastructure.
- Snehal Antani spent two decades preparing to found Horizon3. Investors put it above $2B
The former IBM, GE, Splunk and JSOC executive used each job as founder training, then survived a funding drought and the SVB collapse.
- VistIQ seeks $12.5M to commercialize Founders Future's AI system
The SEC filing shows $2.3M sold to 11 investors as Severine Gregoire and Marc Menase commercialize software first built inside Founders Future.
- Polaris Electro-Optics discloses $49.5M financing for AI data-center optics
Founder Cory Pecinovsky left an industry job to commercialize a new liquid-crystal material; Polaris has now raised about $62.5M across disclosed financings.
- AlgoX2 sells $4.52M in offering targeting $12M
The filing follows a $3.5M Bessemer-led seed in October 2025 and leaves the five investors, valuation and detailed security terms unnamed.
- Helogen raises $7.1M before two October orbital biomaterial missions
Shishir Bankapur plans to put Helogen's seed financing behind HEL-IOS hardware, two October flights and the manufacturing data needed to pursue medical uses on Earth.
- Episteme Prognostics sells $5.1M in ongoing $6.02M offering for pancreatic cancer test
Episteme Prognostics has sold $5.09M of a $6.02M equity offering, while its PancEpistemeDx test still lacks prospective clinical proof.
- Backbone raises €4M to pull food compliance out of spreadsheets
The former Henchman operators are building AI agents for supplier records, lab results and audits, with Agristo and Darta on the cap table.
- Superluminal raises $60M to move its GPCR obesity drug into Phase 1
BVF led the round as founders Cony D'Cruz and Ajay Yekkirala prepare an oral MC4R agonist for human testing by year-end.
- Dravite Therapeutics discloses $53M financing without naming a drug program
Founded in 2025, Dravite Therapeutics has reported nearly $68M in equity sales across two offerings; its filings do not identify a drug program or participating investors.
- Atira raises $17.5M after landing industrial customers without a sales team
Accel led the $15M seed as Palantir and Google alumni Florian Diegruber and August DuMont Schuette prepare Atira's first commercial hires.
- Resect AI raises $25M to inspect and modify enterprise LLM behavior
Kevin Owens and three co-founders are betting enterprise buyers will pay for model-level intervention beyond dashboards that score bad answers.
- TrndX raises $3.175M to make an AI cloud fit in a rack
The fully sold equity offering gives optical-switching veteran Jitender Miglani fresh capital for TrndX's UniFlex infrastructure platform.
- Thinking Machines seeks $1B-plus at a $40B valuation after last fall's $50B ask
The lower target still values Mira Murati's AI lab at more than three times its July 2025 post-money price.